Your browser doesn't support javascript.
loading
A multicenter, randomized, active-controlled study to investigate the efficacy and safety of intravenous ferric carboxymaltose in patients with iron deficiency anemia.
Onken, Jane E; Bregman, David B; Harrington, Robert A; Morris, David; Acs, Peter; Akright, Bruce; Barish, Charles; Bhaskar, Birbal S; Smith-Nguyen, Gioi N; Butcher, Angelia; Koch, Todd A; Goodnough, Lawrence T.
Afiliação
  • Onken JE; Duke Clinical Research Institute, Durham, North Carolina; Luitpold Pharmaceuticals, Inc., Norristown, Pennsylvania; Albert Einstein College of Medicine, New York, New York; Stanford University School of Medicine, Stanford, California; Webb Writes, LLC, Durham, North Carolina; Gainesville Hematology Oncology Associates, Gainesville, Florida; Northeast OB/GYN Associates, San Antonio, Texas; Wake Gastroenterology, Wake Research Associates, Raleigh, North Carolina; Medical Oncology Care Associates,
Transfusion ; 54(2): 306-15, 2014 Feb.
Article em En | MEDLINE | ID: mdl-23772856
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Compostos Férricos / Anemia Ferropriva / Maltose Tipo de estudo: Clinical_trials / Etiology_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2014 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Compostos Férricos / Anemia Ferropriva / Maltose Tipo de estudo: Clinical_trials / Etiology_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2014 Tipo de documento: Article